Otipax (Phenazone, Lidocaine Hydrochloride)

Phenazone, the active ingredient in Otipax, is an analgesic and local anesthetic presented as a topical ear formulation for auricular use. It relieves pain and discomfort associated with ear conditions in adults and children. GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otipax combines phenazone and lidocaine to provide symptomatic relief in ear‑related conditions. It is used for: - Otitis media: reduces pain and pressure in the middle ear. - External ear canal irritation: eases discomfort from minor abrasions or inflammation. - Post‑procedural ear discomfort: alleviates pain after otoscopic examinations or minor ear surgeries. - Earwax removal procedures: minimizes pain during mechanical removal of cerumen. - Acute otitis externa: helps control pain associated with swimmer’s ear. - Ear pain in children: provides age‑appropriate analgesia for mild ear discomfort.

Otipax may cause adverse reactions at the site of application or systemically.

Common Side Effects: - Mild burning or stinging sensation in the ear. - Transient itching or mild erythema of the external canal. - Temporary tinnitus or ringing sensation. - Minor dizziness following application.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling or rash. - Severe ototoxicity presenting as hearing loss. - Persistent vertigo or balance disturbances. - Systemic hypersensitivity reactions such as urticaria or anaphylaxis.

Before using Otipax, consider the following safety measures: - Assess for ear perforation: avoid use if tympanic membrane is ruptured. - Check for known hypersensitivity: discontinue if allergic reaction occurs. - Use with caution in children under six months: consult a healthcare professional. - Avoid concurrent use with other otic anesthetics: reduce risk of cumulative toxicity. - Do not apply to infected or inflamed ear canals without medical advice. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Otipax may interact with other medications applied to the ear or systemic agents that affect hearing.

Major Interactions (Avoid): - Concurrent otic aminoglycoside antibiotics: increased risk of ototoxicity. - Systemic quinidine or quinine: potential additive cardiac effects.

Moderate Interactions (Monitor Closely): - Other topical anesthetics: cumulative local anesthetic effect. - Anticoagulant therapy: heightened risk of ear bleeding if trauma occurs. - CYP 3‑4